Abstract
Purpose
To measure the outcome of emergency cervical cerclage (ECC) combined with progesterone vs. progesterone alone in pregnancy prolongation for preterm labor at 24–28 weeks.
Methods
One hundred patients in early labor were allocated randomly into two equal groups. Group A were treated by ECC and progesterone, and group B were on the same progesterone dose only treatment.
Results
No significant differences were observed in both groups as regard demographic data, fetal gestational age or cervical state on admission. However, a significant pregnancy prolongation was observed in group A (28.44 ± 12.73 days vs. 9.96 ± 3.27 in group B, p < 0.001) with subsequent increase in fetal gestational age (32.04 ± 3.2 vs. 27.86 ± 3.213, p < 0.001), heavier weight, higher Apgar score at 1 and 5 min, and lower rate of cesarean delivery (1033.1 ± 170.83 vs. 715.1 ± 138.73, p < 0.001) (2.68 ± 1.132 vs. 2.14 ± 0.93, p < 0.001), (5.48 ± 2.6 vs. 2.38 ± 1.59, p = 0.01) and (16 vs. 62 %, p = 0.01), respectively. Also neonatal outcomes in terms of early neonatal deaths were lower in this group (18 vs. 46 %, p = 0.049).
Conclusions
ECC is effective in pregnancy prolongation when judiciously used in combination with progesterone compared to progesterone alone.
Similar content being viewed by others
Change history
17 February 2023
An Editorial Expression of Concern to this paper has been published: https://doi.org/10.1007/s00404-023-06978-x
References
American College of Obstetricians and Gynecologists (2001) ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31, October 2001. Obstet Gynecol 98(4):709–716
ACOG practice bulletin (2003) Management of preterm labor. Number 43. Int J Gynaecol Obstet 82(1):127–135
Eden RD, Penka A, Britt DW, Landsberger EJ, Evans MI (2005) Re-evaluating the role of the MFM specialist: lead, follow, or get out of the way. J Matern Fetal Neonatal Med 18(4):253–258
Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL (2012) Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 4:CD008991. (PMID22513970)
Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J (2011) Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 117(3):663–671. (PMID21446209)
Beck S, Wojdyla D, Say L et al (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88(1):31–38
Rafael TJ, Berghella V, Alfirevic Z (2014) Cervical stitch (cercelage) for preventing preterm birth in multiple pregnancies. Cochrane Database Syst Rev. doi:10.1002/14651858.CD009166.pub2.PMID25208049
McDonald IA (1957) Suture of the cervix for inevitable miscarriage. J Obstet Gynaecol Br Emp 64:712–714
ACOG Committee on Obstetric Practice (2011) ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 117:422
Abu Hashim H, Al-Inany H, Kilani Z (2014) A review of the contemporary evidence on rescue cervical cerclage. Int J Gynaecol Obstet 124(3):198–203
Practice Bulletin No (2014) 142: cerclage for the management of cervical insufficiency. Obstet Gynecol 123(2 Pt 1):372–379
US Department of Health and Human Sciences (2012) Guidelines summary NGC9419. ACOG 10:127
Althuisius SM, Dekker GA, Hummel P, van Geijn HP (2003) Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest vs. bed rest alone. Am J Obstet Gynecol 189:907–910
Lorene T. Cerclage alone vs. cerclage and 17 Alpha-Hydroxyprogesterone for the prevention of preterm Birth. Abstract 78, 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists (ACOG). 2013
Keeler SM, Kiefer D, Rochon M, Quinones JN, Novetsky AP, Rust O (2009) A randomized trial of cerclage vs 17 α-hydroxyprogesterone caproate for treatment of short cervix. J Perinat Med 37:473–479
Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA (2013) Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. doi:10.1002/14651858.CD004947.pub3
Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E et al (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206(124):e1–e19. doi:10.1016/j.ajog.2011.12.003
Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O’Brien JM, Cetingoz E et al (2013) Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison meta-analysis. Am J Obstet Gynecol 208:e41–e42. doi:10.1016/j.ajog.2012.10.877
DeFranco EA, O’Brien JM, Adair CD et al (2007) Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Obstet Gynecol 30:697–705
Cetingoz E, Cam C, Sakalli M et al (2011) Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 283:423–429
Agustin C-A, Roberto R, Medsci D, Nicolaides K, Chaiworapongsa T, John M, O’brien O, Cetingoz E, Da Fonseca E, Creasy G, Priya S, Shalini F, Cetin C, Zarko A, Sonia S, Hassan S (2013) Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, singleton gestation, and previous preterm birth: a systematic review and indirect comparison meta-analysis. Am J Obstet Gynecol 208(1):42e1–42e18
Szychowski JM, Berghella V, Owen J, Hankins G, Iams JD, Sheffield JS, Perez-Delboy A, Wing DA, Guzman ER (2012) Vaginal ultrasound trial consortium. cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 25(12):2686–2689. doi:10.3109/14767058.2012.717128 (Epub 2012 Aug 24)
Berghella V, Figueroa D, Szychowski JM et al (2010) 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 202(4):351e1–351e6
Rafael TJ, MacKeen AD, Berghella V (2011) The effect of 17-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. Am J Perinatol 28(5):389–393
Rebarber J, Cleary-Goldman NB, Istwan I et al (2008) The use of 17 alpha-hydroxyprogesterone caproate (17P) in women with cervical cerclage. Am J Perinatol 25(5):271–275
Northen AT, Norman GS, Anderson K, Moseley L et al (2007) For the National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Follow-up of children exposed in utero to 17 a-hydroxyprogesterone caproate compared with placebo. Obstet Gynecol 110(4):865–872
Acknowledgments
The authors would like to thank their colleagues in the Obstetrics and Gynecology department who offer the maximum care to the patients during their hospital stay.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ragab, A., Mesbah, Y. To do or not to do emergency cervical cerclage (a rescue stitch) at 24–28 weeks gestation in addition to progesterone for patients coming early in labor? A prospective randomized trial for efficacy and safety. Arch Gynecol Obstet 292, 1255–1260 (2015). https://doi.org/10.1007/s00404-015-3772-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3772-4